Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

Patent metadata

Field	Value
Publication number	US-10786595-B2
Application number	US-201514883483-A
Country	US
Kind code	B2
Filing date	Oct 14, 2015
Priority date	Mar 24, 2011
Publication date	Sep 29, 2020
Grant date	Sep 29, 2020

Abstract

According to an illustrative embodiment a method to promote healing of a wound is provided comprising contacting the wound with a biologically active composition comprising a lipoic acid derivative and gelatin. In another embodiment a topical composition is provided, which can be formulated as a homogenous mixture, such as a spray, mist, aerosol, lotion, cream, solution, oil, gel, ointment, paste, emulsion or suspension or applied on a carrier material, such as a bandage, gauze, foam, sponge, hydrogel, hydrocolloid, hydrofiber, occlusive dressing, adhesive composition or scaffold. Methods for producing such a topical composition and carrier material with the topical composition applied thereto are also disclosed.

First claim

We claim:

1. A wound dressing for applying treatment to a tissue site comprising:
a carrier material having a lower portion adapted to contact the tissue site and an upper portion opposite the lower portion; and
a first layer on the carrier material, the first layer comprising a lipoic acid derivative; and
a second layer over the first layer, the second layer comprising a sacrificial proteolytic enzyme substrate.

2. The wound dressing of claim 1 , wherein the sacrificial proteolytic enzyme substrate comprises gelatin.

3. The wound dressing of claim 1 , wherein the carrier material comprises a bandage, gauze, foam, sponge, hydrogel, hydrocolloid, hydrofiber, occlusive dressing, adhesive composition or scaffold.

4. The wound dressing of claim 1 , wherein the carrier material comprises a bioresorbable material.

5. The wound dressing of claim 4 , wherein the bioresorbable material comprises at least one of polyglycolic acid, polylactic acid, polydioxanone, polyhydroxybutyrate, polyhydrozyvalerate, polyaminoacids polyorthoesters, polyvinly alcohol, collagen, gelatin, chitosan, oxidized regenerated cellulose, hyaluronic acid, or alginate.

6. The wound dressing of claim 1 , wherein the carrier material comprises a non-bioresorbable material.

7. The wound dressing of claim 6 , wherein the non-bioresorbable material comprises at least one of polyurethane, polyvinyl alcohol foam or gauze.

8. The wound dressing of claim 1 , further comprising a drape adapted to be positioned adjacent to the upper portion of the carrier material and provide a fluid seal around the carrier material.

9. The wound dressing of claim 1 , wherein the sacrificial proteolytic enzyme substrate comprises at least one of keratin, collagen, elastin, gelatin, casein, albumin, fibrinogen, fibronectin, soy protein, wheat protein, corn protein, milk proteins and/or hydrolysates thereof.

10. A wound dressing for treating a tissue site, comprising:
a carrier material adapted to contact the tissue site; and
a composition consisting essentially of a first layer of a lipoic acid derivative on the carrier material and a second layer of a sacrificial proteolytic enzyme substrate over the first layer of lipoic acid derivative.

11. The wound dressing of claim 10 , wherein the sacrificial proteolytic enzyme substrate comprises gelatin.

12. The wound dressing of claim 10 , wherein the sacrificial proteolytic enzyme substrate comprises collagen.

13. The wound dressing of claim 10 , wherein the carrier material comprises a polyurethane open-cell foam.

14. The wound dressing of claim 10 , wherein the carrier material comprises a collagen.

15. The wound dressing of claim 10 , wherein:
the carrier material comprises a polyurethane foam; and
the sacrificial proteolytic enzyme substrate comprises gelatin.

16. The wound dressing of claim 10 , wherein the sacrificial proteolytic enzyme substrate comprises at least one of keratin, collagen, elastin, gelatin, casein, albumin, fibrinogen, fibronectin, soy protein, wheat protein, corn protein, milk proteins and/or hydrolysates thereof.

17. A wound dressing for applying treatment to a tissue site comprising:
a carrier material having a lower portion adapted to contact the tissue site and an upper portion opposite the lower portion; and
a lipoic acid derivative and a sacrificial proteolytic enzyme substrate applied to the upper portion of the carrier material;
wherein the lipoic acid derivative is applied to the upper portion of the carrier material as a first layer and the sacrificial proteolytic enzyme substrate is applied as a second layer over the first layer of lipoic acid derivative.

18. The wound dressing of claim 17 , wherein the lipoic acid derivative and the sacrificial proteolytic enzyme substrate form a homogenous mixture.

19. The wound dressing of claim 17 , wherein the sacrificial proteolytic enzyme substrate comprises gelatin.

20. The wound dressing of claim 17 , wherein the carrier material comprises a bandage, gauze, foam, sponge, hydrogel, hydrocolloid, hydrofiber, occlusive dressing, adhesive composition or scaffold.

21. The wound dressing of claim 17 , wherein the carrier material comprises a bioresorbable material.

22. The wound dressing of claim 21 , wherein the bioresorbable material comprises at least one of polyglycolic acid, polylactic acid, polydioxanone, polyhydroxybutyrate, polyhydrozyvalerate, polyaminoacids polyorthoesters, polyvinly alcohol, collagen, gelatin, chitosan, oxidized regenerated cellulose, hyaluronic acid, or alginate.

Assignees

• Kci Licensing Inc

Inventors

• Zimnitsky Dmitry
• Finkbiner Jenny
• Sanders Blane

Classifications

• A61L15/64 Primary

  specially adapted to be resorbable inside the body · CPC title

• A61M1/916 Primary

  specially adapted for deep wounds · CPC title

• A61M1/915

  Constructional details of the pressure distribution manifold · CPC title

• A61K33/38

  Silver; Compounds thereof · CPC title

• A61L15/26

  Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)} · CPC title